← Open Payments lookup

MEGAN ROBERTSON: Open Payments

NPI 1912520438 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$533 in 27 payments from 18 companies in 2025. Trend: 2023 $42 · 2024 $566 · 2025 $533

Food & beverage: $533
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$101
Abbott Laboratories1$60
Otsuka America Pharmaceutical, Inc.2$56
ABBVIE INC.2$43
Corcept Therapeutics3$43
Lilly USA, LLC2$38
Eisai Inc.1$24
GlaxoSmithKline, LLC.1$23
Biogen, Inc.1$17
Bayer Healthcare Pharmaceuticals Inc.1$17

Products named: CAPLYTA, FREESTYLE LIBRE 3, REXULTI, VRAYLAR, Korlym, MOUNJARO, Leqembi, TRELEGY ELLIPTA.

Industry payments across KS — which companies pay providers there.